Patents by Inventor Fraser Hunt

Fraser Hunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pteridine compounds for the treatment of psoriasis
    Patent number: 7579342
    Abstract: The invention provides pteridine compounds of formula (I), processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy. Formula (I) in which A is a group of formula (a) or (b).
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: August 25, 2009
    Assignee: AstraZeneca
    Inventors: Roger Bonnert, Stewart Gardiner, Fraser Hunt, Iain Walters
  • Imidazol derivatives of piperidine as histamine antagonists
    Publication number: 20070185163
    Abstract: Piperidine compounds according to Formula I wherein R1, m, X, n, p, q, Y, Z and Ar are acs defined in the specification, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy and in the preparation of medicaments.
    Type: Application
    Filed: July 19, 2004
    Publication date: August 9, 2007
    Applicant: AstraZeneca AB
    Inventors: Fraser Hunt, Peter Hamley
  • Pyrimidine compounds and their use as modulators of chemokine receptor activity
    Patent number: 6958344
    Abstract: The invention provides certain heterocyclic compounds, processes, and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy; in formula (I), A is a group of formula (a) or (b).
    Type: Grant
    Filed: February 7, 2001
    Date of Patent: October 25, 2005
    Assignee: AstraZeneca AB
    Inventors: Roger Bonnert, Peter Cage, Fraser Hunt, Iain Walters, Paul Willis
  • Thiazolopyrimidines and their use as modulators of chemokine receptor activity
    Patent number: 6958343
    Abstract: Compounds of formula (I): are described herein. The compounds can be used, for example, in the treatment of chemokine mediated diseases, including inflammatory diseases such as psoriasis and COPD.
    Type: Grant
    Filed: February 7, 2001
    Date of Patent: October 25, 2005
    Assignee: AstraZeneca, AB
    Inventors: Roger Bonnert, Peter Cage, Fraser Hunt, Robert Jewell, Iain Walters
  • Pyrimidine compounds and their use as modulators of chemokine receptor activity
    Publication number: 20050234077
    Abstract: The invention provides certain heterocyclic compounds, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy; in formula (I), A is a group of formula (a) or (b).
    Type: Application
    Filed: January 14, 2005
    Publication date: October 20, 2005
    Inventors: Roger Bonnert, Peter Cage, Fraser Hunt, Iain Walters, Paul Willis
  • Pteridine compounds for the treatment of psoriasis
    Publication number: 20050171345
    Abstract: The invention provides pteridine compounds of formula (I), processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy. Formula (I) in which A is a group of formula (a) or (b).
    Type: Application
    Filed: July 15, 2004
    Publication date: August 4, 2005
    Inventors: Roger Bonnert, Stewart Gardiner, Fraser Hunt, Iain Walters
  • Pteridine compounds for the treatment of psoriasis
    Patent number: 6875868
    Abstract: The invention provides pteridine compounds of formula (I), processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy. Formula (I) in which A is a group of formula (a) or (b).
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: April 5, 2005
    Assignee: AstraZeneca AB
    Inventors: Roger Bonnert, Stewart Gardiner, Fraser Hunt, Iain Walters
  • Compounds
    Patent number: 6806273
    Abstract: The invention provides certain thiazolopyrimidine compounds, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: October 21, 2001
    Date of Patent: October 19, 2004
    Assignee: AstraZeneca AB
    Inventors: Rupert Austin, Andrew Baxter, Roger Bonnert, Fraser Hunt, Elizabeth Kinchin, Paul Willis
  • Sealing ring for connecting two especially insertable concrete components
    Publication number: 20030107189
    Abstract: A scaling ring (1) for sealing an annular gap between a concrete pipe socket and a concrete pipe spigot end is adapted to be mounted on a mould ring intended for casting of a concrete pipe comprising a socket so as to be fixed in the socket by said casting. The scaling ring is made in one piece by means of co-extrusion of a soft rubber material and a hard rubber material. The soft rubber material has a hardness of 30-40 IRHD and forms a radially inner sealing layer (6), which is intended to abut against the mould ring during said casting and to abut sealingly against the spigot end during use of the sealing ring (1). The hard rubber material forms a second layer (7) located radially outside the radially inner sealing layer.
    Type: Application
    Filed: August 9, 2002
    Publication date: June 12, 2003
    Inventors: Roger Bonnert, Fraser Hunt, Paul Willis
  • Pteridine compounds for the treatment of psoriasis
    Publication number: 20030055250
    Abstract: The invention provides pteridine compounds of formula (I), processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy. Formula (I) in which A is a group of formula (a) or (b).
    Type: Application
    Filed: August 22, 2002
    Publication date: March 20, 2003
    Inventors: Roger Bonnert, Stewart Gardiner, Fraser Hunt, Iain Walters
  • Pyrimidine compounds and their use as modulators of chemokine receptor activity
    Publication number: 20030040523
    Abstract: The invention provides certain heterocyclic compounds, processes, and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy; in formula (I), A is a group of formula (a) or (b).
    Type: Application
    Filed: August 9, 2002
    Publication date: February 27, 2003
    Inventors: Roger Bonnert, Peter Cage, Fraser Hunt, Iain Walters, Paul Willis
  • Thiazolopyrimidines and thier use as modulators of chemokine receptor activity
    Publication number: 20030032642
    Abstract: The invention provides certain thiazolopyrimidine compound, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: August 9, 2002
    Publication date: February 13, 2003
    Inventors: Roger Bonnert, Peter Cage, Fraser Hunt, Robert Jewell, Iain Walters